Evaluating the In Vitro Activity and Safety of Modified LfcinB Peptides as Potential Colon Anticancer Agents: Cell Line Studies and Insect-Based Toxicity Assessments

• Karen J. Cárdenas-Martínez,
• Andrea C. Barragán-Cárdenas,
• Manuela de la Rosa-Arbeláez,
• Claudia M. Parra-Giraldo,
• Alejandra Ochoa-Zarzosa,
• Joel E. Lopez-Meza,
• Zuly J. Rivera-Monroy,
• Ricardo Fierro-Medina,
• Javier E. García-Castañeda

Affiliations

Karen J. Cárdenas-Martínez

†Department of Pharmacy, Universidad Nacional de Colombia, Bogotá, Colombia

Andrea C. Barragán-Cárdenas

‡Department of Biotechnology, Universidad Nacional de Colombia, Bogotá, Colombia

Manuela de la Rosa-Arbeláez

§Deparment of Chemistry, Universidad Nacional de Colombia, Bogotá, Colombia

Claudia M. Parra-Giraldo

Proteomics and Human Mycosis Unit, Infectious Diseases Research Group, Department of Microbiology, Pontificia Universidad Javeriana, Bogotá, Colombia

Alejandra Ochoa-Zarzosa

Multidisciplinary Centre for Studies in Biotechnology, Universidad Michoacana de San Nicolas de Hidalgo, Tarímbaro, México

Joel E. Lopez-Meza

Multidisciplinary Centre for Studies in Biotechnology, Universidad Michoacana de San Nicolas de Hidalgo, Tarímbaro, México

Zuly J. Rivera-Monroy

§Deparment of Chemistry, Universidad Nacional de Colombia, Bogotá, Colombia

Ricardo Fierro-Medina

§Deparment of Chemistry, Universidad Nacional de Colombia, Bogotá, Colombia

Javier E. García-Castañeda

†Department of Pharmacy, Universidad Nacional de Colombia, Bogotá, Colombia